OpenAI CEO Sam Altman raises $252 million for brain computer interface venture — but Merge Labs is still in an early research phase

OpenAI CEO Sam Altman has secured $252 million in funding for Merge Labs, a brain computer interface (BCI) venture. Merge Labs, co-founded by Altman, is still in the early research phase but aims to revolutionize BCIs by using new technologies like ultrasound and molecules instead of electrodes. The investment places Merge Labs as one of the most heavily funded BCI efforts in the U.S., second only to Neuralink. The company's approach contrasts with Neuralink's focus on invasive implants, opting for non-invasive methods. The funding will primarily support research efforts to develop new BCI technologies, emphasizing AI operating systems that can interpret intent reliably.